Can I just interrupt, Dr. Tunis, and put something to you? Last week Dr. Andrew Morris expressed concern that individuals cannot really receive informed consent regarding the risk of VITT prior to getting a second dose of AstraZeneca, given the constant changing data being received about the incidence of VITT. He had numbers showing that it's continually changing.
Although there's emerging data, is there conclusive data, at this point, to make an informed decision on the safety concerns of AstraZeneca or on mixed dosage? Or is that data shifting and moving?